BIOA
BioAge Labs Inc.

489
Mkt Cap
$837.97M
Volume
151,657.00
52W High
$24.00
52W Low
$2.88
PE Ratio
-9.49
BIOA Fundamentals
Price
$19.05
Prev Close
$20.07
Open
$20.02
50D MA
$19.15
Beta
1.22
Avg. Volume
591,357.33
EPS (Annual)
-$1.98
P/B
2.59
Rev/Employee
$0.00
$138.07
Loading...
Loading...
News
all
press releases
BioAge Labs (NASDAQ:BIOA) Given New $52.00 Price Target at Citigroup
Citigroup lifted their price objective on BioAge Labs from $15.00 to $52.00 and gave the stock a "buy" rating in a research note on Tuesday...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
BioAge Labs (NASDAQ:BIOA) Shares Gap Down - Here's Why
BioAge Labs (NASDAQ:BIOA) Shares Gap Down - Here's What Happened...
MarketBeat·10d ago
News Placeholder
BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Update
BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) was the recipient of a large increase in short interest during the month of February. As of February 13th, there was short interest totaling...
MarketBeat·11d ago
News Placeholder
BioAge Labs Touts Oral NLRP3 Inhibitor BGE-102 Data, Eyes CV Study and Retinal Expansion
BioAge Labs (NASDAQ:BIOA) outlined its strategy and near-term clinical plans at Oppenheimer's 36th Annual Life Science Conference, emphasizing its focus on using human aging biology to develop...
MarketBeat·14d ago
News Placeholder
Oppenheimer Begins Coverage on BioAge Labs (NASDAQ:BIOA)
Oppenheimer initiated coverage on shares of BioAge Labs in a research report on Wednesday. They set an "outperform" rating and a $60.00 target price on the stock...
MarketBeat·15d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Shares Gap Up - Time to Buy?
BioAge Labs (NASDAQ:BIOA) Shares Gap Up - What's Next...
MarketBeat·22d ago
News Placeholder
BioAge Labs, Inc. (NASDAQ:BIOA) Given Consensus Rating of "Hold" by Analysts
BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) has been assigned an average recommendation of "Hold" from the three analysts that are currently covering the stock, MarketBeat reports. One equities...
MarketBeat·22d ago
News Placeholder
BioAge Labs, Inc. (NASDAQ:BIOA) Short Interest Down 16.3% in January
BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) was the target of a large drop in short interest during the month of January. As of January 30th, there was short interest totaling 909,129 shares, a...
MarketBeat·24d ago
News Placeholder
BioAge Labs (NASDAQ:BIOA) Trading Down 5.6% - Here's What Happened
BioAge Labs (NASDAQ:BIOA) Trading Down 5.6% - Here's Why...
MarketBeat·1mo ago
News Placeholder
BLA for subcutaneous formulation of Leqembi designated for Priority Review in China
BLA for subcutaneous formulation of Leqembi designated for Priority Review in China BLA for subcutaneous formulation of Leqembi designated for Priority Review in China PR Newswire STOCKHOLM, Feb. 9...
PR Newswire·1mo ago
<
1
2
...
>

Latest BIOA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.